Stockscreener 앱 받기
13.09
4.56%
0.59
전일 마감가:
$12.50
열려 있는:
$12.81
하루 거래량:
679.61K
Relative Volume:
0.56
시가총액:
$964.27M
수익:
$193.35M
순이익/손실:
$-177.58M
주가수익비율:
-5.3429
EPS:
-2.45
순현금흐름:
$-172.43M
1주 성능:
+10.76%
1개월 성능:
-2.17%
6개월 성능:
-31.10%
1년 성능:
-38.00%
1일 변동 폭
$12.59
$13.12
1주일 범위
$11.43
$13.36
52주 변동 폭
$11.11
$27.63
슈뢰딩거 Stock (SDGR) Company Profile
명칭
Schrodinger Inc
전화
503-299-1150
주소
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, TEM, BTSG, HQY, WAY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
13.09 | 920.81M | 193.35M | -177.58M | -172.43M | -2.45 |
|
VEEV
Veeva Systems Inc
|
186.92 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
51.61 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.71 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
82.47 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.85 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
슈뢰딩거 Stock (SDGR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-15 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-09-30 | 개시 | Goldman | Neutral |
| 2025-08-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-08-14 | 개시 | Barclays | Overweight |
| 2025-07-03 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-07-02 | 개시 | Leerink Partners | Outperform |
| 2023-12-05 | 개시 | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | 재개 | Piper Sandler | Overweight |
| 2022-12-19 | 개시 | Goldman | Neutral |
| 2022-03-01 | 개시 | Citigroup | Buy |
| 2021-11-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | 개시 | Piper Sandler | Overweight |
| 2021-11-11 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-10-13 | 개시 | Berenberg | Buy |
| 2021-09-01 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | 개시 | Craig Hallum | Buy |
| 2020-11-23 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-10-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-03-02 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-02 | 개시 | Jefferies | Hold |
| 2020-03-02 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
슈뢰딩거 주식(SDGR)의 최신 뉴스
[144] Schrodinger, Inc. SEC Filing - Stock Titan
Vanguard Group Inc. Has $127.16 Million Holdings in Schrodinger, Inc. $SDGR - MarketBeat
Schrodinger (NASDAQ: SDGR) CEO gets options, sells shares under 10b5-1 - Stock Titan
Schrodinger (SDGR) CFO receives new stock options and RSU grants - Stock Titan
Schrodinger (NASDAQ: SDGR) EVP granted stock options and RSU awards - Stock Titan
Schrodinger (NASDAQ: SDGR) CTO Lorton receives new stock and option awards - Stock Titan
Schrodinger (SDGR) CAO Jenny Herman receives new RSU and option awards - Stock Titan
Schrodinger (SDGR) executive granted 48,500 options and sells shares for taxes - Stock Titan
Equity grants to Schrodinger (NASDAQ: SDGR) officer include options and RSUs - Stock Titan
Schrodinger (SDGR) executive receives new RSUs and stock option grant - Stock Titan
Schrodinger, Inc. (SDGR) Stock Analysis: Investors Eye a Potential 93% Upside Amid Market Turbulence - DirectorsTalk Interviews
Schrodinger, Inc. (NASDAQ:SDGR) Given Average Rating of "Hold" by Brokerages - MarketBeat
Schrodinger, Inc. (SDGR) Transition to Licensing Model Triggers Robust Revenue Growth - Finviz
Schrödinger, Inc. (SDGR) Transition to Licensing Model Triggers Robust Revenue Growth - Insider Monkey
Schrödinger (SDGR) Valuation After 2025 Results And Shift To Hosted Licensing Model - simplywall.st
Assessing Schrödinger (SDGR) Valuation After Full Year 2025 Earnings And AI Platform Progress - Yahoo Finance
Does Schrödinger’s 2025 Revenue Surge And Narrower Loss Reshape The Bull Case For SDGR? - simplywall.st
SDGR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Medline, Inc. Class A (MDLN) and Silence Therapeutics (SLN) - The Globe and Mail
Schrodinger Inc. (SDGR) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Schrodinger (NASDAQ:SDGR) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat
Schrödinger, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:SDGR) 2026-02-26 - Seeking Alpha
Schrodinger Q4 Earnings Call Highlights - MarketBeat
Schrodinger Inc (SDGR) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Transition Challenges - GuruFocus
Schrödinger (SDGR) Reports Strong 2025 Revenue Growth and Strate - GuruFocus
Earnings Call Summary | Schrodinger(SDGR.US) Q4 2025 Earnings Conference - 富途牛牛
Schrodinger (NASDAQ:SDGR) Announces Quarterly Earnings Results, Beats Estimates By $0.57 EPS - MarketBeat
Schrodinger Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results - PharmiWeb.com
SDGR: 23% revenue growth in 2025, strong ACV, and hosted transition drive future profitability - TradingView
Earnings call transcript: Schrödinger Q4 2025 revenue beats forecast, shares rise - Investing.com
SDGR: Revenue up 23% to $255.9M, net loss narrows, and cash reserves remain strong - TradingView
Schrödinger, Inc. (SDGR) Stock Analysis: Unveiling a 126.78% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Schrödinger to Participate in Upcoming March 2026 Investor Conferences - BioSpace
Earnings Preview For Schrodinger - Benzinga
Schrödinger to Participate in Upcoming Investor Conferences - PharmiWeb.com
Schrodinger (NASDAQ:SDGR) Reaches New 52-Week LowShould You Sell? - MarketBeat
SDGR Technical Analysis & ETF Price Forecast - Intellectia AI
Schrödinger, Inc. Hits New 52-Week Low at USD 11.11 - Markets Mojo
Schrodinger's Pivotal Earnings Report Approaches () - aktiencheck.de
Jupiter Asset Management Ltd. Acquires Shares of 234,625 Schrodinger, Inc. $SDGR - MarketBeat
Top 3 health care stocks that could lead to your biggest gains in Q1 - MSN
Top 3 Health Care stocks That Could Lead To Your Biggest Gains In Q1 - Fidelity
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Schrodinger (SDGR) Projected to Post Earnings on Wednesday - MarketBeat
Schrodinger, Inc. (SDGR) Investor Outlook: Unpacking A 123% Potential Upside - DirectorsTalk Interviews
How (SDGR) Movements Inform Risk Allocation Models - Stock Traders Daily
Schrodinger (NASDAQ:SDGR) CAO Sells $10,370.08 in Stock - MarketBeat
Schrodinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25 - marketscreener.com
Schrodinger stock hits 52-week low at 12.8 USD By Investing.com - Investing.com Canada
Schrodinger (NASDAQ:SDGR) EVP Sells $10,708.80 in Stock - MarketBeat
슈뢰딩거 (SDGR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.33%
0.50%
자본화:
|
볼륨(24시간):